© 2021 MJH Life Sciences and Patient Care Online. All rights reserved.
© 2021 MJH Life Sciences™ and Patient Care Online. All rights reserved.
The FDA approved today the first drug that targets the pathophysiolgic process responsible for Alzheimer disease and the first drug since 2003 to be approved for any Alzheimer treatment.
Underweight means highest risk, say researchers.
This adult beverage may actually provide health benefits, specifically for Alzheimer, Parkinson, and other neurological conditions.